Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention

Journal of Neurosurgery

Volumn 89, Issue 2, 1998, Pages 267-274

  Watts, Colin ^a,b,c   Dunnett, Stephen B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC Clinical Training Fellowship ^*

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Clinical trial; Embryonic graft; Excitotoxic dose; Graft morphology; Host striatal damage; Huntington's disease; Rat; Striatal transplant

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN GRAFT; CORPUS STRIATUM; FEMALE; GRAFT SURVIVAL; HUNTINGTON CHOREA; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL TECHNIQUE;

EID: 0031815611     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.89.2.0267     Document Type: Article

References (69)

1. Bakay RAE: Selection criteria for CNS grafting into Parkinson's disease patients, in Lindvall O, Bjorklund A, Widner H (eds): Intracerebral Transplantation in Movement Disorders. Restorative Neurology, Vol 4. London: Elsevier, 1991, pp 137-148
2. Bakker MHM, Foster AC: An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo. Neuroscience 42: 387-395, 1991
3. Beal MF, Ferrante RJ, Swartz KJ, et al: Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 11:1649-1659, 1991
4. Beal MF, Kowall NW, Ellison DW, et al: Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171, 1986
5. Beal MF, Kowall NW, Swartz KJ, et al: Systemic approaches to modifying quinolinic acid striatal lesions in rats. J Neurosci 8: 3901-3908, 1988
6. Bjorklund A, Dunnett SB: Neural transplantation in adult rats, in Dunnett SB, Bjorklund A (eds): Neural Transplantation: A Practical Approach. Oxford: IRL Press at Oxford University Press, 1992, pp 57-78
7. Campbell K, Wictorin K, Björklund A: Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents. Proc Natl Acad Sci USA 89:10489-10493, 1992
8. Campbell K, Wictorin K, Björklund A: Neurotransmitter-related gene expression in intrastriatal striatal transplants - I. Phenotypical characterization of striatal and non-striatal graft regions. Neuroscience 64:17-33, 1995
9. Campbell K, Wictorin K, Björklund A: Neurotransmitter-related gene expression in intrastriatal striatal transplants - II. Characterization of efferent projecting graft neurons. Neuroscience 64:35-47, 1995
10. Clarke DJ, Dunnett SB, Isacson O, et al: Striatal grafts in rats with unilateral neostriatal lesions - I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 24:791-801, 1988
11. Coyle JT: An animal model for Huntington's disease. Biol Psychiatry 14:251-276, 1979
12. Coyle JT, Schwarcz R: Lesion of striatal neurones with kainic acid provides a model for Huntington's disease. Nature 263: 244-246, 1976
13. Dunnett SB, Bjorklund A: Staging and dissection of rat embryos, in Dunnett SB, Bjorklund A (eds): Neural Transplantation: A Practical Approach. Oxford: IRL Press at Oxford University Press, 1992, pp 15-16
14. Emerich DF, Zubricki EM, Shipley MT, et al: Female rats are more sensitive to the locomotor alterations following quinolinic acid-induced striatal lesions: effects of striatal transplants. Exp Neurol 111:369-378, 1991
15. Freeman TB, Sanberg PR, Isacson O: Development of the human striatum: implications for fetal striatal transplantation in the treatment of Huntington's disease. Cell Transplant 4: 539-545, 1995
16. Fricker RA, Barker RA, Fawcett JW, et al: A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures and in vivo grafts. Cell Transplant 5:599-611, 1996
17. Flicker RA, Torres EM, Dunnett SB: The effects of donor stage on the survival and function of embryonic striatal grafts in rat brain. I. Morphological characteristics. Neuroscience 79: 695-710, 1997
18. Fricker RA, Torres EM, Hume SP, et al: The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79:711-721, 1997
19. Furtado JCS, Mazurek MF: Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease. Exp Neurol 138:158-168, 1996
20. Graybiel AM, Liu FC, Dunnett SB: Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization. J Neurosci 9:3250-3271, 1989
21. Gundersen HJG, Bagger P, Bendtsen TF, et al: The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881, 1988
22. Gundersen HJG, Bendtsen TF, Korbo L, et al: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96:379-394, 1988
23. c-src+ mRNAs in the developing and grafted rat striatum. Mol Brain Res 41:90-96, 1996
24. Hedreen JC, Folstein SE: Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 54:105-120, 1995
25. Hedreen JC, Peyser CE, Folstein SE, et al: Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-261, 1991
26. Helm GA, Palmer PE, Bennett JP: Choline acetyltransferase-and substance P-like immunoreactive elements in fetal striatal grafts in the rat: a correlated light and electron microscopic study. Neuroscience 47:621-639, 1992
27. Helm GA, Palmer PE, Bennett JP: Fetal neostriatal transplants in the rat: a light and electron microscopic Golgi study. Neuroscience 37:735-756, 1990
28. Hemmings HC Jr, Walaas SI, Ouimet CC, et al: Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32. Trends Neurosci 10:377-383, 1987
29. Isacson O, Brundin P, Gage FH, et al: Neural grafting m a rat model of Huntington's disease. Progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience 16:799-817, 1985
30. Isacson O, Brundin P, Kelly PAT, et al: Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned striatum. Nature 311:458-460, 1984
31. Isacson O, Dawbarn D, Brundin P, et al: Neural grafting in a rat model of Huntington's disease: striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry immunocytochemistry, and receptor autoradiography. Neuroscience 22:481-497, 1987
32. Kopyov OV, Jaques S, Kurth M, et al: Neurotransplantation of fetal lateral ganglionic eminence tissue in three patients with Huntington's disease. Soc Neurosci Abstracts 22:227, 1996 (Abstract)
33. Labandeira-Garcia JL, Wictorin K, Cunningham ET Jr, et al: Development of intrastriatal striatal grafts and their afferent innervation from the host. Neuroscience 42:407-426, 1991
34. Levivier M, Gash DM, Przedborski S: Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum. Neuroscience 69:43-50, 1995
35. Liu FC, Graybiel AM, Dunnett SB, et al: Intrastriatal grafts derived from fetal striatal primordia: II. Reconstitution of cholinergic and dopaminergic systems. J Comp Neurol 295:1-14, 1990
36. Madrazo I, Franco-Bourland RE, Castrejon H, et al: Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurol Res 17:312-315, 1995
37. Martin JB Gusella JF: Huntington's disease. Pathogenesis and management. N Engl J Med 315:1267-1276, 1986
38. 2 dopamine receptors in primordial striatal tissue grafts in rats. Neurosci Lett 109:271-276, 1990
39. Morris BJ, Wisden W, Dunnett SB, et al: Cellular localisation of somatostatin mRNA and neuropeptide Y mRNA in foetal striatal tissue grafts. Neurosci Lett 103:121-126, 1989
40. Nakao N, Grasbon-Frodl EM, Widner H, et al: Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 73:185-200, 1996
41. Nakao N, Odin P, Lindvall O, et al: Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp Neurol 138:144-157, 1996
42. Ouimet CC, Miller PE, Hemmings HC Jr, et al: DARPP-32, a dopamine and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions III. Immunocytochemical localization. J Neurosci 4:111-124, 1984
43. Pearlman S, Levivier M, Collier TJ, et al: Striatal implants protect the host striatum against quinolinic acid toxicity. Exp Brain Res 84:303-310, 1991
44. Pearlman S, Levivier M, Gash DM: Striatal implants of fetal striatum or gelfoam protect against quinolinic acid lesions of the striatum. Brain Res 613:203-211, 1993
45. Peschanski M, Cesaro P, Hantraye P: Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68:273-285, 1995
46. Portera-Cailliau C, Hedreen JC, Price DL, et al: Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15:3775-3787, 1995
47. Portera-Cailliau C, Price DL, Martin LJ: Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol 378:88-104, 1997
48. Pritzel M, Isacson O, Brundin P, et al: Afferent and efferent connections of striatal grafts implanted into ibotenic acid lesioned neostriatum in adult rats. Exp Brain Res 65:112-126, 1986
49. Pundt LL, Narang N, Kondoh T, et al: Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease. Neurosci Res 27:305-315, 1997
50. Quinn N, Brown R, Craufurd D, et al: Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov Disord 11:143-150, 1996
51. Reiner A, Albin RL, Anderson KD, et al: Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733-5737, 1988
52. Roberts RC, Difiglia M: Localization of immunoreactive GABA and enkephalin and NADPH-diaphorase-positive neurons in fetal striatal grafts in quinolinic acid-lesioned rat neostriatum. J Comp Neurol 274:406-421, 1988
53. Roberts RC, DiFiglia M: Long-term survival of GABA-, enkephalin-, NADPH-diaphorase-and calbindin-d28k-containing neurons in fetal striatal grafts. Brain Res 532:151-159, 1990
54. Roos RAC, Pruyt JFM, deVries J, et al: Neuronal distribution in the putamen in Huntington's disease. J Neurol Neurosurg Psychiatry 48:422-425, 1985
55. Sanberg PR, Calderon SF, Giordano M, et al: The quinolinic acid model of Huntington's disease: locomotor abnormalities. Exp Neurol 105:45-53, 1989
56. Sanberg PR, Zubrycki EM, Ragozzino ME, et al: NADPH-diaphorase containing neurons and cytochrome-oxidase activity following striatal quinolinic acid lesions and fetal striatal transplants. Prog Brain Res 82:427-431, 1990
57. Schwarcz R, Whetsell WO Jr, Mangano RM: Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316-318, 1982
58. Shannon KM, Kordower JH: Neural transplantation for Huntington's disease: experimental rationale and recommendations for clinical trials. Cell Transplant 5:339-352, 1996
59. Sirinathsinghji DJS, Wisden W, Northrop A, et al: Cellular localisation of neurotransmitter mRNAs in striatal grafts. Prog Brain Res 82:433-439, 1990
60. Sofroniew MV, Dunnett SB, Isacson O: Remodelling of intrinsic and afferent systems in neocortex with cortical transplants. Prog Brain Res 82:313-320, 1990
61. Thian S, Watts C, Everitt BJ, et al: The effect of interval between lesion and transplantation on striatal graft survival and integration in the quinolinic acid-lesioned neostriatum of rats. Soc Neurosci Abstracts 22:580, 1996 (Abstract)
62. Vonsattel JP, Myers RH, Stevens TJ, et al: Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577, 1985
63. Walaas SI, Greengard P: DARPP-32, A dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions I. Regional and cellular distribution in the rat brain. J Neurosci 4:84-98, 1984
64. Walker PD, Chovanes GI, McAllister JP II: Identification of acetylcholinesterase-reactive neurons and neuropil in neostriatal transplants. J Comp Neurol 259:1-12, 1987
65. Watts C, Dunnett SB, Rosser AE: Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Exp Neurol 148: 271-280, 1997
66. Wictorin K, Ouimet CC, Björklund A: Intrinsic organization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immunohistochemistry: specificity of connections with the lesioned host brain. Eur J Neurosci 1: 690-701, 1989
67. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12: 1040-1062, 1992
68. Xu ZC, Wilson CJ, Emson PC: Morphology of intracellularly stained spiny neurons in rat striatal grafts. Neuroscience 48: 95-110, 1992
69. Xu ZC. Wilson CJ, Emson PC: Synaptic potentials evoked in spiny neurons in rat neostriatal grafts by cortical and thalamic stimulation. J Neurophysiol 65:477-493, 1991